David F Clanachan Net Worth

The estimated Net Worth of David F Clanachan is at least $305 mil dollars as of 26 July 2024. David Clanachan owns over 129,534 units of Tilray Brands Inc stock worth over $305,238 and over the last 3 years David sold TLRY stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

David Clanachan TLRY stock SEC Form 4 insiders trading

David has made over 5 trades of the Tilray Brands Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently David exercised 129,534 units of TLRY stock worth $237,047 on 26 July 2024.

The largest trade David's ever made was exercising 129,534 units of Tilray Brands Inc stock on 26 July 2024 worth over $237,047. On average, David trades about 31,884 units every 109 days since 2021. As of 26 July 2024 David still owns at least 177,464 units of Tilray Brands Inc stock.

You can see the complete history of David Clanachan stock trades at the bottom of the page.

What's David Clanachan's mailing address?

David's mailing address filed with the SEC is C/O TILRAY BRANDS, INC., 265 TALBOT STREET WEST, LEAMINGTON, A6, N8H 4H3.

Insiders trading at Tilray Brands Inc

Over the last 6 years, insiders at Tilray Brands Inc have traded over $92,844,538 worth of Tilray Brands Inc stock and bought 140,416 units worth $933,182 . The most active insiders traders include Irwin D Simon, Brendan Kennedy, eMitchell Gendel. On average, Tilray Brands Inc executives and independent directors trade stock every 13 days with the average trade being worth of $215,593. The most recent stock trade was executed by Irwin D Simon on 31 July 2024, trading 706,214 units of TLRY stock currently worth $1,433,614.

What does Tilray Brands Inc do?

tilray is a global leader in medical cannabis research and production dedicated to providing safe, consistent and reliable therapy to patients. we are the only gmp certified medical cannabis producer currently supplying products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers in australia, canada, the european union and the americas.

Complete history of David Clanachan stock trades at Tilray Brands Inc

Tilray Brands Inc executives and stock owners

Tilray Brands Inc executives and other stock owners filed with the SEC include:

• Irwin David Simon,
  Pres, CEO & Chairman
• Andrew Pucher,
  Chief Corporate Development Officer
• Brendan Kennedy,
  President, Chief Executive Officer, Director
• James R. Meiers,
  Chief Operations Officer
• Denise Menikheim Faltischek,
  Head of International & Chief Strategy Officer
• Carl A. Merton CA, CBV, CPA,
  CFO & Principal Accounting Officer
• Katy Dickson,
  President, Manitoba Harvest USA, LLC
• Katie Turner,
  IR Contact Officer
• Christine St.Clare,
  Independent Director
• Soren Schroder,
  Independent Director
• Rebekah Dopp,
  Independent Director
• Michael Auerbach,
  Independent Director
• Jon Levin,
  Chief Operating Officer
• Michael Kruteck,
  Chief Financial Officer
• Mitch Gendell,
  Global Gen. Counsel & Corp. Sec.
• Roger Savell,
  Chief Admin. Officer
• Rita Seguin,
  Chief HR Officer
• Bernard Yeung,
  Sr. VP of Sales & Marketing
• Mitch Gendel,
  Global Gen. Counsel & Corp. Sec.
• Dara Redler,
  Interim Chief Legal Officer & Corp. Sec.
• John B. Sadler,
  VP of Investor Relations
• Lloyd Brathwaite,
  Chief Information Officer
• Maryscott Greenwood,
  Director
• Edward Wood Jr Pastorius,
  Chief Revenue Officer
• Mark Castaneda,
  CFO, Secretary, Treasurer
• Kathryn P Dickson,
  President- Manitoba Harvest
• Renah Persofsky,
  Director
• Johann Michael Herhalt,
  Director
• James R. Meiers,
  Chief Operations Officer
• David F Clanachan,
  Director
• Denise M Faltischek,
  Chief Strategy Officer
• Mitchell Gendel,
  Global General Counsel
• Carl A Merton,
  Chief Financial Officer
• David G. Hopkinson,
  Director
• Walter E Iv Robb,
  Director
• Thomas P. Looney,
  Director
• Jodi L. Butts,
  Director
• Irwin D Simon,
  President and CEO